✦ LIBER ✦

A randomised controlled trial on pegylated interferon alfa-2a (40kd) (Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV

✍ Scribed by A. Mangia; G.L. Ricci; N. Minerva; M. Persico; V. Carretta; D. Bacca; M. Cela; M. Piattelli; D. di Festi; M. Annese; V. Guadagnino; F. Spirito; A. Andriulli

Book ID: 118566080
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 145 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80794-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2A (40KD) (PEGASYS) p

Peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (roferon-A) plus RBV and AMA in IFN/RBV nonresponder patients with chronic hepatitis C (CHC)

✍ S. Fargion; M. Borzio; A. Cargnel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 312 KB

Re-treatment of interferon (IFN) plus ri

Re-treatment of interferon (IFN) plus ribavirin (RBV) nonresponders with peginterferon (PEG-IFN) Alfa-2A (40KD) (Pegasys) plus RBV and amantadine (AMA) or IFN Alfa-2A (Roferon-A) plus RBV and AMA. Interim results of a multicenter randomized study

✍ S. Brillanti; A. Mangia; L. Cimino; A. Civolani; F. Fatuzzo; L. Fenoglio; M. Lev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

PEG-IFN alfa-2a (40kd) (Pegasys) plus am

PEG-IFN alfa-2a (40kd) (Pegasys) plus amantadine (AMA) or ribavirin (RBV) in naïve patients with chronic hepatitis C (CHC)

✍ G. Ideo; A. Attili; G. Ruggiero; A. Craxi; G. Di Perri; A. Mangia; A. Picciotto; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

475 Sustained virological response (SVR)

475 Sustained virological response (SVR) to peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (Roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C (CHC)

✍ S. Fargion; M. Borzio; A. Maraschi; A. Cargnel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Pegylated 40KDA IFN alfa-2a plus amantad

Pegylated 40KDA IFN alfa-2a plus amantadine (AMA) or ribavirin (RBV) in naives with chronic hepatitis C (CHC): the HIMPCT (Hepatitis Italian Multicenter Pegasys Amantadine Cooperative Trial)

✍ Gaetano Ideo; Mario Angelico; A. Chirianni; Antonio Craxi; G. Di Perri; L. Minol 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A randomized controlled trial of pegylat

A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C

✍ A. Mangia; G. L. Ricci; M. Persico; N. Minerva; V. Carretta; D. Bacca; M. Cela; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB